复方扁咽宁对急性咽炎大鼠疗效及其机制

目的:观察复方扁咽宁对急性咽炎大鼠的治疗作用及其作用机理,为其临床应用提供依据。方法:采用氨水直接喷雾法复制大鼠急性咽炎模型,将其随机分为模型组、复方扁咽宁高、中、低剂量组,另取正常大鼠作为对照,每组10只,高、中、低剂量组剂量(g/kg)分别按28.8、14.4、7.2(生药量计)灌胃药物水提液,正常组与模型组给予等量蒸馏水,观察并记录各组大鼠的症状表现;于末次给药24 h后,腹主动脉采血,ELISA法检测血清中IL-1β及TNF-α的含量,采用HE染色法观察各组大鼠肺组织及肺支气管组织形态,透射电镜法观察气管纤毛形态。结果:模型组急性咽炎表现明显:咽部红肿、充血,气管及肺组织出现病理改变,血清中IL-1β及TNF-α的含量显著升高(与正常组比较,P＜0.05),提示造模成功;与模型组相比,复方扁咽宁低、中、高剂量组急性咽炎的症状如咽部红肿、充血等现象得到明显缓解,肺组织及肺支气管组织形态得到明显的改善,血清中IL-1β及TNF-α的含量显著下降,中剂量组和高剂量组疗效更显著。结论:复方扁咽宁可加速急性咽炎的康复进程,改善支气管及肺的组织形态,其作用机制可能与抑制血清IL-1β和 TNF-α的释放等有关。

Therapeutic effects of Bianyanning decoction on acute pharyngitis in rats and its mechanism

Objective:To investigate the therapeutic effects and mechanisms of Bianyanning on acute pharyngitis in rats, and to provide evidence and experimental data for its clinical application. Methods: The acute pharyngitis of rats was induced by spraying ammonia directly to their throat. The model rats were randomly divided into model control group, the high-, medium- and low-dose group of Bianyanning, while normal rats were used as control group, 10 in each group. After the corresponding drug treatment, the symptoms and manifestations of each group were observed and recorded; 24 hours after last gavaging, blood samples of each group were collected from the abdominal aorta. The serum contents of interleukin 1-beta (IL-1β) and tumor necrosis factor alpha (TNF-α) were detected by ELISA. HE method was used to observe the characteristic of the lung tissues and the transmission electron microscopy method was used to observe the trachea cilia. Results: After the treatment, compared with the model control group, the high-, medium- and low-dose group of Bianyanning, the symptoms of acute pharyngitis such as inflamed and congestive throat were relieved obviously. The morphological changes of lung and bronchus tissues were apparently improved. The contents of IL-1β and TNF-α in serum were decreased significantly. Conclusion: Compound Bianyanning can promote the recovering process of acute pharyngitis, improve the morphology of lungs and bronchus, which may be related to inhibiting the releasing of the IL-1β and TNF-α in serum.